Gavis Pharma earns FDA approval for generic painkiller

Somerset, N.J.-based Gavis Pharmaceuticals — a subsidiary of Mumbai-based Lupin Limited — recently earned approval from the Food and Drug Administration for its hydrocodone bitartrate and acetaminophen tablets.

Advertisement

The tablets are intended to relieve moderate to moderately severe pain.

The FDA approved the painkiller as a generic equivalent of Mikart’s hydrocodone bitartrate and acetaminophen tablets.

More articles on supply chain:

FDA adds box warning to birth control device Essure
Fire in Amazon distribution center forces some retailers to pull products off website
Novartis considers selling eye division

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.